Up-Regulation of Erythropoietin Receptor by Nitric Oxide Mediates Hypoxia Preconditioning

被引:36
作者
Chen, Zhi-Yong [1 ]
Wang, Li [1 ]
Asavaritkrai, Pundit [1 ]
Noguchi, Constance Tom [1 ]
机构
[1] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA
关键词
erythropoietin; nitric oxide; hypoxia; neuroprotection; receptor expression; NF-KAPPA-B; RETINAL DEGENERATION; CEREBRAL-ISCHEMIA; TRANSGENIC MICE; ACUTE STROKE; IN-VITRO; EXPRESSION; BRAIN; PROTECTS; NEUROPROTECTION;
D O I
10.1002/jnr.22473
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Erythropoietin (Epo), known to stimulate erythroid progenitor cell survival, proliferation, and differentiation, has been shown to be neuroprotective against brain ischemia in animal models. Both Epo and Epo receptor (EpoR) are expressed in the brain and are up-regulated by hypoxia. Brain Epo signaling can stimulate neural cell survival and prevent neuron apoptosis. Neurons from EpoR null mice exhibit marked increased sensitivity to hypoxia. In endothelial cells, Epo has been shown to stimulate nitric oxide (NO) production, particularly at low pO(2). We found here that the EpoR expression on neural cells and Epo's neuroprotective effect were regulated by NO. Hypoxia increased NO production as well as EpoR expression, and inhibition of NOS activity reduced the proportion of EpoR-expressing neurons induced at low pO(2). Conversely, addition of NO donor to cultures grown under normoxia induced EpoR. Similarly, NO donor increased EpoR promoter activity in a reporter gene assay, suggesting that NO regulates EpoR at the transcription level. Preincubation of neurons with NO results in induction of EpoR, which gives rise to protection against hypoxia even in the absence of exogenous Epo, although at high concentration NO is toxic. These data provide evidence of a role for NO in Epo activity in brain and suggest links between NO production, EpoR expression, and Epo signaling in neuroprotection. Published 2010 Wiley-Liss, Inc.(dagger)
引用
收藏
页码:3180 / 3188
页数:9
相关论文
共 40 条
[1]   Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells [J].
Beleslin-Cokic, BB ;
Cokic, VP ;
Yu, XB ;
Weksler, BB ;
Schechter, AN ;
Noguchi, CT .
BLOOD, 2004, 104 (07) :2073-2080
[2]   NO signaling in the CNS: from the physiological to the pathological [J].
Bishop, A ;
Anderson, JE .
TOXICOLOGY, 2005, 208 (02) :193-205
[3]   Erythropoietin pathophysiology and erythropoietin deficiency anemia [J].
Cazzola, M .
HEMATOLOGY JOURNAL, 2004, 5 :S100-S103
[4]   The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes [J].
Chavez, Juan C. ;
Baranova, Oxana ;
Lin, Janice ;
Pichiule, Paola .
JOURNAL OF NEUROSCIENCE, 2006, 26 (37) :9471-9481
[5]   Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation [J].
Chen, Zhi-Yong ;
Asavaritikrai, Pundit ;
Prchal, Josef T. ;
Noguchi, Constance Tom .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (35) :25875-25883
[6]   REGULATION OF TRANSCRIPTION OF THE HUMAN ERYTHROPOIETIN RECEPTOR GENE BY PROTEINS BINDING TO GATA-1 AND SP1 MOTIFS [J].
CHIN, K ;
ODA, N ;
SHEN, K ;
NOGUCHI, CT .
NUCLEIC ACIDS RESEARCH, 1995, 23 (15) :3041-3049
[7]   Nitric oxide as a bioregulator of apoptosis [J].
Chung, HT ;
Pae, HO ;
Choi, BM ;
Billiar, TR ;
Kim, YM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (05) :1075-1079
[8]   The Beta-hCG plus Erythropoietin in Acute Stroke (BETAS) Study A 3-Center, Single-Dose, Open-Label, Noncontrolled, Phase IIa Safety Trial [J].
Cramer, Steven C. ;
Fitzpatrick, Camille ;
Warren, Michael ;
Hill, Michael D. ;
Brown, David ;
Whitaker, Laura ;
Ryckborst, Karla J. ;
Plon, Lawrence .
STROKE, 2010, 41 (05) :927-931
[9]  
Dame C, 2001, BIOL NEONATE, V79, P228
[10]   Preconditioning-mediated neuroprotection through erythropoietin? [J].
Dawson, TM .
LANCET, 2002, 359 (9301) :96-97